FDA Approved: BIVALIRUDIN — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved the original abbreviated new drug application for bivalirudin from Mylan Institutional LLC, enabling the marketing of a generic anticoagulant. Biva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Heparin-induced Thrombocytopenia
• Myocardial Infarction

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

ORIG AP for BIVALIRUDIN (BIVALIRUDIN)